Subcutaneous EEG tracks epilepsy for 15 months in prospective study

A prospective study running 15 months has examined real-world epilepsy monitoring with ultra-long-term subcutaneous electroencephalography, according to a paper published on Wiley Online Library under the title "Real-world epilepsy monitoring with ultra-long-term subacutaneous electroencephalography: A 15-month prospective study."

The publication concerns subcutaneous EEG, a modality in which electrode(s) are implanted under the scalp rather than glued to the skin surface. The approach targets the central limitation of conventional scalp EEG: recording duration. Routine outpatient scalp recordings typically last 20 to 40 minutes, and inpatient video-EEG monitoring in the epilepsy monitoring unit usually spans days. Ultra-long-term implantable recording extends the observation window to months.

The study design is prospective and spans 15 months of follow-up, the title states. The authors frame the work as "real-world" monitoring, indicating data collection outside a tightly controlled hospital protocol.

What does this change for the reading room?

The practical question for epileptologists and EEG readers is straightforward: does an implantable subcutaneous system deliver interpretable, clinically usable records over timescales no external montage can sustain? A 15-month prospective dataset speaks directly to that question. The full text of the Wiley publication carries the cohort details, signal-quality findings and clinical endpoints; the title confirms the duration and the prospective real-world design.

Ultra-long-term subcutaneous EEG has drawn interest for interictal burden quantification and for measuring seizure frequency in drug-resistant patients between clinic visits, contexts in which sporadic scalp or inpatient recordings systematically undersample the disorder. Sustained ambulatory recording also matters for epilepsy surgery candidates, where confirming seizure counts and localization over long horizons can change candidacy decisions.

Readers should note the distinction between device classes. Subcutaneous EEG systems exist as regulated medical devices in some markets, while individual studies may report investigational use; the publication itself should be consulted for the specific system, regulatory status and implantation protocol.

The Wiley paper is available through Wiley Online Library. Its 15-month prospective, real-world design positions it as one of the longer systematic evaluations of subcutaneous EEG to date, and subsequent work will need to show whether these long-horizon records improve seizure-outcome prediction and management decisions.